Choosing Safer Diabetes Medications for Older Adults, suggests study Dr. Kamal Kant Kohli1 May 2026 9:00 PM ISTOlder adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms yet are often...
SGLT2 Inhibitors Reduce Gout Flares and Medication Use in Type 2 Diabetes: Study Dr Riya Dave24 April 2026 9:30 AM ISTA study published in Diabetes Care has found that SGLT2 inhibitors are associated with fewer gout flares and reduced need for gout-related...
SGLT2 Inhibitors may Increase Risk of Diabetic Ketoacidosis, finds study Dr Kartikeya Kohli20 April 2026 9:00 AM ISTAccording to a new study, SGLT2 inhibitors are linked to an increased risk of diabetic ketoacidosis in patients with type 2 diabetes, especially those...
SGLT2 Inhibitors Do Not Reduce Psoriasis Risk in T2DM: Study Dr Riya Dave17 April 2026 8:00 PM ISTSodium-glucose co-transporter 2 inhibitor (SGLT2i) therapy fails to lower the risk of new-onset psoriasis among patients with type 2 diabetes mellitus...
SGLT2 Inhibitors exhibit greater BP lowering effect compared to DPP-4 Inhibitors: Study Jacinthlyn Sylvia16 April 2026 9:00 PM ISTA recent study published in the International Journal of Molecular Sciences revealed that patients initiating sodium-glucose cotransporter 2 (SGLT2)...
Add on Dapagliflozin to Insulin Pump Superior to add on Metformin for Glycemic Control in Diabetes: Study Dr Riya Dave13 April 2026 9:30 AM ISTResearchers have found in a new study that dapagliflozin combined with intensive insulin pump therapy provides better glycemic control than metformin...
SGLT2 Inhibitors tied to Superior Cardiorenal and Hepatic Outcomes in Diabetes patients With Cirrhosis: JAMA Jacinthlyn Sylvia7 March 2026 9:30 AM ISTA recent study published in the Journal of the American Medical Association revealed that the use of sodium-glucose cotransporter-2 inhibitors (SGLT2...
What are Benefits and Risks of SGLT2 Inhibitors in Diabetic Kidney Disease? Jacinthlyn Sylvia5 March 2026 8:30 PM ISTA new study published in the journal of Frontiers in Endocrinology showed that patients with diabetic kidney disease (DKD) benefit greatly from...
SGLT-2 Inhibitors Improve Cardiac Function and Symptoms in Hypertrophic Cardiomyopathy: Study Jacinthlyn Sylvia4 March 2026 9:30 AM ISTA new study published in the journal of Frontiers in Cardiovascular Medicine revealed that Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) were...
Dapagliflozin May Reduce Liver Fat in Type 2 Diabetes Independent of Weight Loss: Study Dr Riya Dave24 Feb 2026 9:30 AM ISTResearchers have found in a secondary analysis of a clinical trial published in Obesity that taking dapagliflozin 10 mg daily for 12 months was...
SGLT2 Inhibitors Show Superior Kidney Outcomes Compared to GLP-1 Receptor Agonists: JAMA Jacinthlyn Sylvia5 Feb 2026 8:30 PM ISTA new study published in the Journal of American Medical Association showed that when renal protection is a primary therapeutic objective, starting...
Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function Dr. Kamal Kant Kohli18 Jan 2026 8:00 PM ISTIn late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two companion papers in JAMA,...
